Mary Pitman, PhD, is a Staff Research Scientist at SandboxAQ, where she leads technological innovation in drug discovery and biologics. Dr. Pitman's groups develop new computational methods in antibody design, cell-scale AI models, and affinity prediction techniques for small molecules and biologics. Her background includes scientific software engineering for pharmaceutical and AI companies, academia, and the NIH. As a postdoctoral MolSSI software fellow, Dr. Pitman worked with David Mobley and discovered new AI and graph theoretic methods for drug discovery. During her doctorate, Dr. Pitman studied under Garegin Papoian as an Integrative Cancer Research fellow at the NCI/NIH. There, she derived new theoretical frameworks to model how epigenetics drive cancer.